Blockchain Moon Acquisition Corp. (BMAQ) Reverses Decision to Liquidate
by Marlena Haddad on 2023-03-16 at 5:56pm

After announcing its intent to liquidate yesterday, Blockchain Moon Acquisition Corp.(NASDAQ:BMAQ) disclosed this afternoon that it no longer plans to dissolve its trust and will instead continue its search for an alternative target to combine with.

The decision to liquidate followed the SPAC’s unilateral termination of its $163 million deal with Web 3.0 infrastructure builder DLTx ASA (OSX:DLTX). Just yesterday, Blockchain Moon’s sponsor, Jupiter Sponsor LLC, stated that due to the deal termination, it would not contribute any additional funds to its trust account.

But, the SPAC has now retracted its statement and the sponsor anticipates that it will continue to contribute funds to the SPAC’s trust.

Blockchain Moon initially planned on funding the DLTx deal with $115.8 million from its trust, but redemptions took out 84.56% of the account during an extension vote held in October 2022, leaving it with $17.87 million post-vote. The SPAC has already used 2 of its 6 one-month extensions and if it plans to use the rest of its extensions available, it will have until July 21 to complete a business combination.

Recent Posts
by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

by Nicholas Alan Clayton on 2024-04-16 at 7:58am

At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...

by Nicholas Alan Clayton on 2024-04-15 at 3:47pm

AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved